Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Once Daily 3TC, Efavirenz and ddI for HIV Infection

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2005 by 407 Doctors.
Recruitment status was  Recruiting
Bristol-Myers Squibb
Merck Sharp & Dohme Corp.
Information provided by:
407 Doctors Identifier:
First received: September 16, 2005
Last updated: October 21, 2005
Last verified: September 2005
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given